Scancell to present at the Annual Immuno-Oncology Summit Europe To download click here Wednesday 17 April 2024 11:56 Categories: Immunobody Modi-1 News Regulatory News SCIB1 Year - 2024
Scancell presents positive data from the first stage in its Phase 2 SCOPE trial at the 20th International Congress of the Society for Melanoma Research To download click here Friday 10 November 2023 09:30 Categories: Immunobody News Regulatory News SCIB1 Year - 2023
Update on SCIB2 clinical development partnership Do download click here Wednesday 3 February 2021 09:45 Categories: Immunobody News Regulatory News SCIB2 Year - 2021
Proactive Investors Presentation, 27th August 2020 (video link) <iframe></div> Tuesday 1 September 2020 09:00 Categories: AvidiMab Covid-19 Immunobody Moditope Presentations Year - 2020
Scancell to present six posters at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference To download click here Thursday 26 September 2019 07:00 Categories: Immunobody News Regulatory News Year - 2019
Scancell at the frontier of cancer therapy The Shares magazine August 2019 Spotlight profile of Scancell. Click here to view. Friday 30 August 2019 17:00 Categories: Immunobody Moditope News Year - 2019
Shares Magazine Investor Presentation At the Forefront of Immuno-Oncology The Shares Magazine Investor Evening presentation from 17 July 2019 is now available. Click here to view. To review further documents and presentations, please click here. Wednesday 17 July 2019 13:00 Categories: Immunobody Modi-1 Moditope News Presentations SCIB1 Year - 2019
Scancell surges after announcing milestone in development of its solid tumours treatment Scancell has a clinical development partnership with Cancer Research UK, the world's leading cancer charity dedicated to saving lives through research [View article] Monday 20 May 2019 11:23 Categories: Immunobody Media Coverage SCIB2 Year - 2019
Scancell Holdings wins Japanese patent protection It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia [View article] Monday 8 April 2019 13:20 Categories: Immunobody Media Coverage SCIB1 SCIB2 Year - 2019
Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise [View article] Tuesday 12 February 2019 20:07 Categories: Immunobody Media Coverage Modi-1 Modi-2 SCIB1 SCIB2 Year - 2019